Literature DB >> 23890943

Has the association between hysterectomy and ovarian cancer changed over time? A systematic review and meta-analysis.

Susan J Jordan1, Christina M Nagle, Michael D Coory, Diane Maresco, Melinda M Protani, Neha A Pandeya, Kanchana D Balasubramaniam, Penelope M Webb.   

Abstract

Until recently most studies suggested that hysterectomy with ovarian conservation was associated with a decreased risk of ovarian cancer. However, several recent studies have reported modestly increased risks of ovarian cancer following hysterectomy. Given that as many as 35% of women will have a hysterectomy, the nature of the association requires clarification. We conducted a systematic review and meta-analysis of the published literature on the relationship between hysterectomy and ovarian cancer to investigate whether there has been a temporal change in the association. Twenty observational studies that have reported a quantitative assessment of the association between hysterectomy and risk of histologically-confirmed ovarian cancer were included in the meta-analysis. The overall relative risk (RR) estimate was 0.81 (95% confidence interval (CI) 0.72-0.92) suggesting hysterectomy decreases the risk of ovarian cancer. However, there was significant heterogeneity in the results (I(2) = 74%). Our exploration of sources of heterogeneity and metaregression showed that median year of cancer diagnosis of included cases explained most of the heterogeneity relative risk (RR = 0.70 (95% CI 0.65-0.76) for median year diagnosis pre 2000; RR = 1.18 (95% CI 1.06-1.31) for post 2000). This study shows that there has been a temporal shift in the association between hysterectomy and risk of ovarian cancer. One explanation may be the trend away from hysterectomy in younger women. Other speculative possibilities include the decline in oophorectomy rates and the use of oestrogen-only hormone replacement therapy in hysterectomised women. Until further evidence becomes available, clinicians should not advise women that a hysterectomy without salpingo-oophorectomy will favourably influence their future risk of ovarian cancer.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hysterectomy; Meta-analysis; Ovarian cancer; Risk

Mesh:

Year:  2013        PMID: 23890943     DOI: 10.1016/j.ejca.2013.07.005

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

1.  Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.

Authors:  Lauren C Peres; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Sarah E Abbott; Fabian Camacho; Frances Wang; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

2.  50-year trends in US socioeconomic inequalities in health: US-born Black and White Americans, 1959-2008.

Authors:  Nancy Krieger; Anna Kosheleva; Pamela D Waterman; Jarvis T Chen; Jason Beckfield; Mathew V Kiang
Journal:  Int J Epidemiol       Date:  2014-03-16       Impact factor: 7.196

3.  Response to van Diest, Zweemer, and Piek.

Authors:  Suzanne C Dixon-Suen; Penelope M Webb; Louise F Wilson; Karen Tuesley; Louise M Stewart; Susan J Jordan
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

4.  The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study.

Authors:  Suzanne C Dixon-Suen; Penelope M Webb; Louise F Wilson; Karen Tuesley; Louise M Stewart; Susan J Jordan
Journal:  J Natl Cancer Inst       Date:  2019-10-01       Impact factor: 13.506

5.  Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.

Authors:  Lilah Khoja; Rachel Palmieri Weber; Penelope M Webb; Susan J Jordan; Aruna Muthukumar; Jenny Chang-Claude; Renée T Fortner; Allan Jensen; Susanne K Kjaer; Harvey Risch; Jennifer Anne Doherty; Holly R Harris; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Andrew Berchuck; Joellen M Schildkraut; Daniel Cramer; Kathryn L Terry; Hoda Anton-Culver; Argyrios Ziogas; Minh Tung Phung; Gillian E Hanley; Anna H Wu; Bhramar Mukherjee; Karen McLean; Kathleen Cho; Malcolm C Pike; Celeste Leigh Pearce; Alice W Lee
Journal:  Gynecol Oncol       Date:  2021-11-12       Impact factor: 5.304

6.  Racial Differences in Population Attributable Risk for Epithelial Ovarian Cancer in the OCWAA Consortium.

Authors:  Lauren C Peres; Traci N Bethea; Tareq F Camacho; Elisa V Bandera; Alicia Beeghly-Fadiel; Deanna L Chyn; Holly R Harris; Charlotte E Joslin; Patricia G Moorman; Evan Myers; Heather M Ochs-Balcom; Will Rosenow; V Wendy Setiawan; Anna H Wu; Lynn Rosenberg; Joellen M Schildkraut
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

7.  Adverse childhood experiences are associated with increased risk of hysterectomy and bilateral oophorectomy: A national retrospective cohort study of women in England.

Authors:  Panayotes Demakakos; Andrew Steptoe; Gita D Mishra
Journal:  BJOG       Date:  2022-02-08       Impact factor: 7.331

8.  Relationship between female hormonal and menstrual factors and pancreatic cancer: a meta-analysis of observational studies.

Authors:  Bo Tang; Jiannan Lv; Yang Li; Shengguang Yuan; Zhenran Wang; Songqing He
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

9.  The Association between Endometriosis, Tubal Ligation, Hysterectomy and Epithelial Ovarian Cancer: Meta-Analyses.

Authors:  Chunpeng Wang; Zhenzhen Liang; Xin Liu; Qian Zhang; Shuang Li
Journal:  Int J Environ Res Public Health       Date:  2016-11-14       Impact factor: 3.390

10.  Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies.

Authors:  Lauren C Peres; Harvey Risch; Kathryn L Terry; Penelope M Webb; Marc T Goodman; Anna H Wu; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa L Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Ani Manichaikul; Sarah E Abbott; Fabian Camacho; Susan J Jordan; Christina M Nagle; Mary Anne Rossing; Jennifer A Doherty; Francesmary Modugno; Kirsten Moysich; Roberta Ness; Andrew Berchuck; Linda Cook; Nhu Le; Angela Brooks-Wilson; Weiva Sieh; Alice Whittemore; Valerie McGuire; Joseph Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Celeste L Pearce; Chiuchen Tseng; Malcom Pike; Joellen M Schildkraut
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.